Search

Your search keyword '"De Matthaeis N."' showing total 88 results

Search Constraints

Start Over You searched for: Author "De Matthaeis N." Remove constraint Author: "De Matthaeis N."
88 results on '"De Matthaeis N."'

Search Results

1. T.07.5: THE PROGNOSTIC ROLE OF THE ELF TEST, COMPARED TO LIVER BIOPSY, IN PATIENTS WITH METABOLIC DYSFUNCTIONASSOCIATED STEATOTIC LIVER DISEASE (MASLD)

2. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept

3. Long-term results from the Italian real-world experience on obeticholic acid treatment in primary biliary cholangitis: The RECAPITULATE study

4. Prediction of response to obeticholic acid in primary biliary cholangitis: Development and validation of the OCA response score (ORS)

5. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma

6. Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications

7. Pattern of macrovascular invasion in hepatocellular carcinoma

8. Non-alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS-NAFLD Study

11. Hepatocellular carcinoma with portal vein tumor thrombus: a single-center retrospective analysis

13. OC-11Development of NAFLD/NASH multidisciplinary board: MetaLiverCat experience

14. Pattern of macrovascular invasion in hepatocellular carcinoma

15. The changing scenario of hepatocellular carcinoma in Italy: an update

16. Multimodal sequential treatment for occluded TIPS: Case report and review of literature

18. Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study

19. MetaLiverCat: the NAFLD/NASH multidisciplinary board at Fondazione Policlinico Gemelli IRCCS

20. Clinical impact of comorbidities in an Italian NAFLD cohort

21. Metabolic disorders across hepatocellular carcinoma in Italy

22. The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study.

23. P.09.23 COMMON CLINICAL COMORBIDITIES IN AN ITALIAN NAFLD COHORT

24. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma

25. LIVER RESECTION AND RADIOFREQUENCY ABLATION IN THE TREATMENT OF SINGLE SMALL (<= 3 CM) HEPATOCELLULAR CARCINOMA (HCC): LONG TERM EFFECTIVENESS IN A MULTICENTER SERIES

26. SCREENING FOR THE IDENTIFICATION OF AUTOIMMUNE OR LYMPHOPROLIFERATIVE ONSET IN PATIENTS NAiVE TO HCV ANTIVIRAL TREATMENT

27. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center

29. Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience

30. 254 SINGLE HEPATOCELLULAR CARCINOMA SMALLER THAN 2 cm: ARE PERCUTANEOUS ETHANOL INJECTION AND RADIOFREQUENCY ABLATION EQUALLY EFFECTIVE?

31. 107 LIVER RESECTION AND RADIOFREQUENCY ABLATION IN THE TREATMENT OF SINGLE SMALL (≤3 CM) HEPATOCELLULAR CARCINOMA (HCC): LONG TERM EFFECTIVENESS IN A MULTICENTER SERIES

34. Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors

35. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey

36. Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma

37. Surveillance for hepatocellular carcinoma with a 3-months interval in 'extremely high-risk' patients does not further improve survival

38. Monofocal hepatocellular carcinoma: How much does size matter?

39. A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma

40. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis.

42. The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma.

43. Non-alcoholic fatty liver disease and the risk of fibrosis in Italian primary care services: GPS-NAFLD Study: GPS-NAFLD Study.

45. A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma.

46. The role of elastography in non-alcoholic fatty liver disease.

47. Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease.

48. Multimodal sequential treatment for occluded TIPS: Case report and review of literature.

49. Congenital extrahepatic portosystemic shunt: description of four cases and review of the literature.

50. Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity.

Catalog

Books, media, physical & digital resources